Hemera Receives Orphan Drug Designation for REMaST® Therapy

Jun 8, 2023 | News, Press Releases

REMaST® Recognized as an Orphan Drug for Acute Spinal Cord Injuries The advanced cell therapy REMaST®, developed by Hemera, has been granted orphan drug designation by the European Commission for the treatment of acute spinal cord injuries. This important recognition...

Changed the structure of the Board of Directors

May 8, 2023 | News

Hemera’s Board of Directors: Updates in its structure For personal reasons, Aldo Cocchiglia is leaving the Board of Directors, effective May 3, 2023. Two years after the birth of Hemera, the shareholders express their gratitude to Ing. Cocchiglia for his...

New Composition of the Board of Directors

May 8, 2023 | News

Hemera Board of Directors: Updates to Its Composition For personal reasons, Aldo Cocchiglia will step down from the Board of Directors effective May 3, 2023. Two years after Hemera’s founding, the shareholders express their gratitude to Mr. Cocchiglia for his...

Hemera achieves an important milestone with the granting of the patent

Apr 21, 2023 | News, Press Releases

The Italian Patent and Trademark Office Officially Recognizes the Patent for REMaST® Therapy The positive evaluation by the Italian Patent and Trademark Office has led to the long-awaited recognition of REMaST® therapy, two years after the patent application was...

Our 2022, step by step

Dec 23, 2022 | News

Our 2022, step by step We close a very intense year that marked significant steps forward in the development of the first cellular therapy for the treatment of acute spinal cord injuries. Hemera has grown and been enriched with new skills, expanding the clinical board...

Hemera enters a new phase and reorganizes governance and scientific team.

Jul 14, 2022 | Press Releases, News

Hemera enters a new phase and reorganizes governance and scientific team. The framework of roles and responsibilities expands Each journey goes through different stages. Hemera enters a new phase, namely the development of the therapy and its evaluation in the...